Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Formycon AG | 3 | 1 | 0 | 0 | €44.35 | €100.00 | 125.479% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.60 | €50.00 | 36.612% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.87 | €30.00 | 945.296% |
| Cytomx Therapeutics Inc | 1 | 2 | 1 | 2 | €1.74 | €25.50 | 1362.995% |
| Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
| Palisade Bio Inc. | 3 | 1 | 1 | 0 | €0.34 | €21.06 | 6072.333% |
| Ocuphire Pharma Inc. | 6 | 1 | 1 | 0 | €1.55 | €18.37 | 1084.903% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | €3.59 | €8.27 | 130.128% |
| Savara Inc. | 1 | 1 | 0 | 1 | €4.62 | €8.00 | 73.160% |
| Trevena Inc. | 2 | 14 | 1 | 1 | €0.35 | €6.48 | 1778.841% |
| Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.69 | €6.43 | 834.520% |
| Revance Therapeutics Inc. | 1 | 2 | 0 | 2 | €2.78 | €3.50 | 25.899% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.96 | €3.00 | 53.453% |
| Minerva Neurosciences Inc. | 1 | 6 | 0 | 1 | €2.34 | €3.00 | 28.205% |
| Organovo Holdings Inc. | 0 | 7 | 0 | 2 | €0.95 | €3.00 | 215.126% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.56 | €3.00 | 431.915% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 2 | €1.04 | €2.00 | 91.663% |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.71 | €1.20 | -29.825% |
| Medigene AG | 1 | 2 | 1 | 0 | €1.43 | €1.00 | -30.070% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €4.12 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.34 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.13 | - | - |